It has been proposed that new atypical antipsychotics cause minimal prolact
in (PRL) elevation compared to traditional antipsychotic agents because the
y spare dopamine blockade within the brain's tuberoinfundibular tract. The
aim of this study was to compare the effects: of olanzapine and haloperidol
on PRL secretion in male schizophrenic patients. Twenty-nine male schizoph
renic inpatients were included in the study. Fifteen of them were given ola
nzapine in a fixed dose of 10 mg/day PO and 14 of them were given haloperid
ol in a fixed dose of 10 mg/day PO for 6 weeks after a 2-week drug washout
period. Fifteen age-matched healthy control subjects were used as control g
roup. PRL levels were measured both before and after the 6-week treatment p
eriod in the patients. At the end of the 6th week, the PRL values observed
with olanzapine treatment were significantly less than those observed with
haloperidol, but not different from those of the controls. There was a sign
ificant positive correlation between the PRL values and the severity of ext
rapyramidal side effects in only the haloperidol group after the six week's
treatment period. Our data indicate that short-term olanzapine treatment a
t doses of 10 mg/day PO causes minimal elevations in PRL secretion in male
schizophrenic patients in contrast to haloperidol. This finding is consiste
nt with the previous reports and may be attributed to olanzapine's differen
tial effects on dopamine neurotransmission. (C) 2001 Elsevier Science Ltd.
All rights reserved.